Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine

Overview of attention for article published in Neurological Sciences, July 2016

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 43 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Botulinum Toxin A for Chronic Migraines: Clinical Effectiveness

Cited by Canadian Agency for Drugs and Technologies in Health on 03 Jan 2018

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.